Vertex also recently won approval from the FDA for its even found that restricting the use of opioids during surgery leads to more post-operative pain. , which potentially offers a cure for the painful blood disorder. CRISPR gene cell therapy for sickle cell disease ..read more

“We are focusing on the fiber as a new neuroscience technology,” Liu says. “We hope to help dissect mechanisms underlying pain in the peripheral nervous system. With time, our technology may help identify novel mechanistic therapies for chronic pain and other debilitating conditions such as nerve degeneration or injury.” , grew out of a desire to expand the use of optogenetics -- a technique in which nerves are genetically engineered to respond to light. Exposure to specific light waves can either activate or inhibit a nerve, giving scientists a new way to study how nerves work.  ..read more

CRPS/RSD is difficult to treat and there is no known cure. Some patients have found relief through show that an SNP in 4 genes (ANO10, P2RX7, PRKAG1 and SLC12A9) was “more common than expected” in patients with CRPS for at least a year (CRPS-1) than it was in the fibromyalgia/back pain group. geneticist at the Cambridge Institute for Medical Research.  “Our data support an underlying genetic predisposition to CRPS-1 in up to a third of cases, with this effect being most prominent in males.” women are more likely to have CRPS ..read more

This article was produced by , which provides free legal representation to low-income residents. They called the plan multiple times to request earlier appointments but got mired in bureaucratic delays and waiting periods. , an editorially independent service of the ..read more

, a non-profit dedicated to bettering the lives of women in pain. She has lived with Complex Regional Pain Syndrome (CRPS) and 19 co-morbidities for four decades, and has been battling cancer since 2020. Cynthia is the author of Cynthia Toussaint is the founder and spokesperson at “Battle for Grace: A Memoir of Pain, Redemption and Impossible Love ..read more

..read more

..read more

“If it can work for me, it can work for anybody,” Justin says. “It’s not guaranteed to work for everybody, but it can work for anybody.” , a non-profit whose mission is to raise funds to provide financial assistance to people with CRPS, primarily for treatment at the Spero Clinic. What makes the foundation different from most other non-profits is that 100% of the donations it receives are applied to treatment costs. And unlike other fundraising platforms like GoFundMe, donors are then able to write it off as a charitable gift on their tax returns. is the Assistant Director of the Building Trad ..read more

This article originally appeared in and is republished with permission. , which train a type of natural cell to be an assassin of the B cell. (MS). Both are “autoimmune” diseases where the immune system attacks its owner instead of the germs it is supposed to fight. , is a clinical rheumatologist and Head of the School of Clinical Sciences at Monash Health, Monash University in Australia.  Dr. Morand consults with companies involved in lupus drug development, including Novartis and AstraZeneca. He receives funding from Australia’s National Health and Medical Research Council and Lupus Res ..read more

The Tennant Foundation gives financial support to Pain News Network and sponsors (redness), pallor, and a mixture of both sweating and atrophy. “Injuries of Nerves and Their Consequences,” (pain) to emphasize the nature of the disorder. Intractable Pain Syndrome Research and Education Project ..read more